Showing results (151-160 of 190) with videos related to
Sort By:
Pageof 19
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 14, 2018
Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida PanelCornelius J Clancy, Peter G Pappas, Jose Vazquez, et al.The New England Journal of Medicine|February 7, 2024
Neurovascular Complications of Iatrogenic Fusarium solani MeningitisNora Strong, Grant Meeks, Sunil A Sheth, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2018
Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE TrialBart Jan Kullberg, Claudio Viscoli, Peter G Pappas, et al.International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 9, 2008
In vitro and in vivo evaluations of increased effective beam width for heat deposition using a split focus high intensity ultrasound (HIFU) transducerPretesh R Patel, Alfred Luk, Amirk Durrani, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2023
Update on Outbreak of Fungal Meningitis Among US Residents Who Received Epidural Anesthesia at Two Clinics in Matamoros, MexicoDallas J Smith, Jeremy A W Gold, Tom Chiller, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2007
Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasisPeter G Pappas, Coleman M F Rotstein, Robert F Betts, et al.Plos One|May 17, 2014
Surveillance of Candida spp bloodstream infections: epidemiological trends and risk factors of death in two Mexican tertiary care hospitalsDora E Corzo-Leon, Tito Alvarado-Matute, Arnaldo L Colombo, et al.Lancet (London, England)|May 8, 2007
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trialErnst-Rüdiger Kuse, Ploenchan Chetchotisakd, Clovis Arns da Cunha, et al.The Lancet. Infectious Diseases|September 8, 2023
Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patientsBenjamin W Teh, Malgorzata Mikulska, Dina Averbuch, et al.Vaccine|May 11, 2019
Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumoniaRaul E Isturiz, Julio Ramirez, Wesley H Self, et al.Pageof 19